Hugues Wallemacq

Hugues Wallemacq is a seasoned professional with extensive experience in the life sciences and biopharmaceutical sectors. Currently serving as Chief Executive Officer and Chief Operations Officer at EXO Biologics since June 2021, Hugues also holds the position of Investment Manager at Noshaq since January 2020. Previous roles include Board Member and Head of Business Development at Unisensor, and Director of Clinical Immuno-Chemistry Assays at GSK. Hugues possesses a PhD in Immunology from the Université de Liège, where research was conducted under the guidance of Pr Fabrice Bureau, as well as an Executive MBA from Maastricht University School of Business and Economics. Starting a career as a Veterinarian in French veterinary clinics, Hugues holds a Doctor of Veterinary Medicine degree from the University of Liège.